Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda
Biotech
Takeda ends mRNA research pact with Japanese drug discoverer
The partnership with Veritas In Silico kicked off in 2023, with a goal of developing new meds for genetically-defined diseases.
Darren Incorvaia
Apr 14, 2026 9:57am
Takeda tears up Denali partnership, returning dementia asset
Apr 6, 2026 1:50pm
Takeda clears path to FDA with phase 3 data on $4B psoriasis bet
Mar 28, 2026 3:00pm
Fierce Pharma
Takeda targets $1.3B in savings with new efficiency drive
Mar 25, 2026 10:44am
Protagonist prefers $400M from Takeda over rusfertide US profits
Feb 26, 2026 10:00am
Angelini nocks an AI arrow with $120M Quiver deal
Feb 23, 2026 11:04am
